Medline Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Medline Inc. (MDLN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income1.200.23-0.03
Depreciation & Amortization0.980.950.93
Deferred Income Tax-0.020.000.00
Stock Based Compensation0.060.080.06
Change in Working Capital-0.680.20-0.92
Change in Accounts Receivable-0.26-0.15-0.38
Change in Inventory-0.550.44-0.20
Change in Accounts Payable0.110.14-0.10
Change in Other Working Capital0.020.23-0.25
Other Operating Activities0.080.230.01
Net Cash from Operating Activities1.771.690.19
Investing Activities
Capital Expenditures-0.36-0.28-0.25
Acquisitions-1.13-0.02-0.02
Purchases of Investments0.00-0.010.01
Other Investing Activities0.000.000.00
Net Cash from Investing Activities-1.49-0.31-0.26
Financing Activities
Debt Repayment-16.16-0.08-0.14
Common Stock Repurchased-0.020.000.00
Dividends Paid-1.52-0.11-0.02
Other Financing Activities-0.010.000.00
Net Cash from Financing Activities-1.61-0.19-0.08
Summary
Effect of Forex Changes on Cash0.000.000.00
Net Change in Cash-1.341.19-0.19
Cash at Beginning of Period1.590.000.00
Cash at End of Period0.250.000.00
Free Cash Flow1.411.41-0.07
Supplemental Disclosures
Interest Paid1.021.130.80
Income Taxes Paid0.100.050.05